Search Results for "intake"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for intake. Results 31 to 40 of 100 total matches.
Methylphenidate Revisited
The Medical Letter on Drugs and Therapeutics • May 06, 1988 (Issue 765)
with stimulants may have difficulty falling asleep and
may decrease food intake enough to lose weight; both ...
Methylphenidate (Ritalin and others), a Schedule II controlled substance in the USA, is a short-acting central-nervous-system stimulant widely used for treatment of children with school performance or behavior problems, or what is now called Attention Deficit-Hyperactivity Disorder, or AD-HD (American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, third ed., revised [DSM-III R], Washington, DC:authors, 1987, p 50). Some studies have estimated that more than 3% of elementary school students are taking methylphenidate, and one parents' group has brought a...
Oral Propranolol (Hemangeol) for Infantile Hemangioma
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014 (Issue 1447)
.
Infants with poor oral intake or concomitant infection
appear to be at greatest risk.2
Propranolol can ...
The FDA has approved an oral solution of the
nonselective beta-adrenergic blocker propranolol
(Hemangeol – Pierre Fabre) for treatment of proliferating
infantile hemangiomas.
Linaclotide (Linzess) for Functional Constipation
The Medical Letter on Drugs and Therapeutics • Aug 21, 2023 (Issue 1683)
intake, increased physical activity, and toilet
training. If first-line treatment is ineffective ...
The guanylate cyclase-C receptor agonist linaclotide
(Linzess – Abbvie/Ironwood) was first approved by
the FDA in 2012 for treatment of chronic idiopathic
constipation and irritable bowel syndrome with
constipation in adults. The drug has now been
approved for treatment of functional constipation in
patients 6-17 years old. Linaclotide is the only drug
to be approved in the US for treatment of functional
constipation.
Med Lett Drugs Ther. 2023 Aug 21;65(1683):135-6 doi:10.58347/tml.2023.1683d | Show Introduction Hide Introduction
Drugs for Hypertriglyceridemia
The Medical Letter on Drugs and Therapeutics • Mar 04, 2013 (Issue 1411)
changes such as weight reduction, exercise
and decreasing alcohol intake can also lower serum ...
Fibrates, niacin and fish oil are promoted for treatment
of hypertriglyceridemia. HMG-CoA reductase inhibitors
(statins) can lower elevated serum concentrations of
triglycerides, but less so than fibrates, niacins or fish oil.
Lifestyle changes such as weight reduction, exercise
and decreasing alcohol intake can also lower serum
triglyceride levels and should be tried first.
Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter on Drugs and Therapeutics • Jun 05, 1998 (Issue 1028)
following oral administration (regardless of food or antacid intake), undergoes extensive first-pass ...
Clopidogrel bisulfate (Plavix - Bristol-Myers Squibb/Sanofi), a new thienopyridine antiplatelet agent similar to ticlopidine (Ticlid - Medical Letter, 34:65, 1992), has been approved by the US Food and Drug Administration (FDA) for secondary prevention of myocardial infarction, stroke and other vascular events.
Potassium Iodide for Thyroid Protection in a Nuclear Accident
The Medical Letter on Drugs and Therapeutics • Apr 04, 2011 (Issue 1361)
prophylaxis after intake of radioactive iodine: a review. Thyroid
2001; 11:353.
3. PB Zanzonico and DV ...
Even though it is unlikely that people living in the US
will be at risk of significant radiation exposure from the
nuclear accident in Japan, some readers have suggested
a review of the use of potassium iodide (KI) in
such circumstances. Potassium iodide taken orally
before or at the time of exposure can limit or prevent
uptake of radioactive iodine by the thyroid gland.
Plenvu - A Low-Volume PEG-Based Colonoscopy Preparation
The Medical Letter on Drugs and Therapeutics • Jan 28, 2019 (Issue 1564)
. Plenvu also contains phenylalanine;
intake of phenylalanine from other sources should be
considered ...
The FDA has approved Plenvu (Salix), a polyethylene
glycol (PEG)-containing oral powder for reconstitution,
for colon cleansing prior to colonoscopy in adults.
Plenvu is the first PEG-containing colonoscopy preparation
that requires only 1 L of water for dissolution and
ingestion of 1 L of clear fluid in addition.
Orlistat for Obesity
The Medical Letter on Drugs and Therapeutics • Jun 18, 1999 (Issue 1055)
of weight loss, but drug-induced adverse effects may also contribute by
causing a decrease in food intake ...
Orlistat, a lipase inhibitor that decreases absorption of fat from the gastrointestinal tract, is now available for treatment of obesity.
Phytoestrogens
The Medical Letter on Drugs and Therapeutics • Feb 21, 2000 (Issue 1072)
-menopausal women found that a large intake of soybean foods
and flaxseed for 12 weeks decreased ...
Phytoestrogens, plant compounds that are converted to estrogens in the gut, are widely promoted as "natural"substitutes for estrogen in hormone replacement therapy.
In Brief: Melamine
The Medical Letter on Drugs and Therapeutics • Oct 20, 2008 (Issue 1297)
from studies in
rats, a tolerable daily intake of 0.63 mg/kg/day.
1
However, the combination of melamine ...
Melamine present in infant formula and other milk products has been associated with widespread illness and some deaths among infants in China. It was also identified in pet food sold in North America after a large number of pets became ill and some died. In both the infants and the pets, renal injury appeared to be the cause.1Melamine (C3H6N6) is a heterocyclic compound, two-thirds nitrogen by weight, that is slightly soluble in water. When combined with formaldehyde, it forms melamine resin, which has a wide variety of industrial applications including the manufacturing of kitchenware,...